Skip to main content
    N

    Nano X Imaging Ltd (NNOX)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.32
    -0.00 (-0.56%)

    Market Cap: $25.36M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Nano X Imaging Ltd (NNOX) Earnings: Report Dates and Results

    Updated Jul 20, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Nano X Imaging (NNOX) is expected to report earnings on Nov 25, 2026. In the quarter ended Jun 30, 2026, Nano X Imaging reported EPS of -$0.79, below the -$0.12 estimate. It beat the EPS estimate in 1 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    44%(11/25)
    Avg Surprise
    -24.92%

    Upcoming Estimates

    Reports Nov 25, 2026 (est.)Period ending Sep 30, 2026
    EPS Consensus-$0.14
    Range-$0.14 - -$0.14
    1 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.11-27.3%
    60d ago-$0.10-40.0%
    30d ago-$0.10-40.0%
    7d ago-$0.10-40.0%
    Current-$0.14
    Revenue Consensus
    $5.45M
    Range$4.58M - $6.33M
    2 analysts
    Reports Apr 19, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.13
    Range-$0.19 - -$0.07
    5 analysts
    Revenue Consensus
    $6.10M
    Range$4.86M - $7.85M
    5 analysts

    Next Report

    NNOX has an expected report date of Nov 25, 2026.

    NNOX Earnings Call

    The latest NNOX earnings call transcript on file is labeled 2026Q2.

    Read the 2026Q2 transcript

    Earnings History

    Of the 25 quarters below that had an estimate, NNOX beat 11, missed 11 and matched 3. Revenue for the quarter ended Jun 30, 2026 was $4.16M, up 36.8% from $3.04M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Jun 30, 2026-$0.79-$0.12-$0.12 - -$0.12-558.33%MissN/A11 up, 0 downJul 20, 2026$4.16M
    Mar 31, 2026-$0.20-$0.14-$0.14 - -$0.14-42.86%MissN/A10 up, 0 downApr 20, 2026$4.31M
    Dec 31, 2025-$0.17-$0.15-$0.15 - -$0.15-13.33%MissN/A21 up, 0 downDec 31, 2025$3.72M
    Sep 30, 2025-$0.15-$0.17-$0.21 - -$0.14+11.76%BeatN/A20 up, 1 downNov 20, 2025$3.45M
    Jun 30, 2025-$0.17-$0.15-$0.16 - -$0.14-13.33%MissN/A21 up, 0 downAug 12, 2025$3.04M
    Mar 31, 2025-$0.15-$0.15-$0.15 - -$0.150.00%In lineN/A21 up, 0 downMay 22, 2025$2.81M
    Dec 31, 2024-$0.17-$0.15-$0.15 - -$0.15-13.33%MissN/A11 up, 0 downMar 31, 2025$3.00M
    Sep 30, 2024-$0.15-$0.15-$0.15 - -$0.150.00%In lineN/A11 up, 0 downNov 21, 2024$3.03M
    Jun 30, 2024-$0.14-$0.15N/A+6.67%BeatN/A30 up, 0 downAug 20, 2024$2.70M
    Mar 31, 2024-$0.21-$0.26-$0.28 - -$0.24+19.23%BeatN/A20 up, 0 downMay 28, 2024$2.55M
    Dec 31, 2023-$0.18-$0.30-$0.38 - -$0.24+40.00%BeatN/A30 up, 0 downMar 14, 2024$2.40M
    Sep 30, 2023-$0.37-$0.30-$0.35 - -$0.26-23.33%MissN/A30 up, 0 downNov 28, 2023$2.48M
    Jun 30, 2023-$0.31-$0.26-$0.30 - -$0.23-19.23%MissN/A20 up, 0 downAug 17, 2023$2.58M
    Mar 31, 2023-$0.21-$0.34-$0.35 - -$0.33+38.24%BeatN/A20 up, 0 downMay 22, 2023$2.45M
    Dec 31, 2022-$0.86-$0.43-$0.57 - -$0.36-100.00%MissN/A30 up, 0 downMar 9, 2023$2.45M
    Sep 30, 2022-$0.37-$0.42-$0.49 - -$0.37+11.90%BeatN/A30 up, 0 downNov 10, 2022$2.44M
    Jun 30, 2022-$0.38-$0.25-$0.30 - -$0.16-52.00%MissN/A30 up, 0 downAug 16, 2022$2.20M
    Mar 31, 2022-$0.41-$0.22-$0.29 - -$0.22-86.36%MissN/A20 up, 0 downMay 19, 2022$1.81M
    Dec 31, 2021-$0.45-$0.33-$0.42 - -$0.25-36.36%MissN/A30 up, 0 downMar 31, 2022$2.20M
    Sep 30, 2021-$0.28-$0.28-$0.30 - -$0.270.00%In lineN/A3N/ANov 17, 2021N/A
    Jun 30, 2021-$0.18-$0.20N/A+10.00%BeatN/A4N/AAug 10, 2021N/A
    Mar 31, 2021-$0.15-$0.27-$0.27 - -$0.24+44.44%BeatN/A2N/AMay 11, 2021N/A
    Dec 31, 2020-$0.18-$0.20-$0.27 - -$0.13+10.00%BeatN/A2N/AMar 2, 2021N/A
    Sep 30, 2020-$0.13-$0.27-$0.33 - -$0.13+51.85%BeatN/A2N/ANov 9, 2020N/A
    Jun 30, 2020-$0.02-$0.23N/A+91.30%BeatN/AN/AN/AJul 31, 2020N/A
    Dec 31, 2019-$0.51N/AN/AN/AN/AN/AN/AN/AJan 14, 2020N/A
    Last 26 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.64, after -$0.67 the year before. It was -$0.51 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.64N/A
    Dec 31, 2024-$0.67N/A
    Dec 31, 2023-$1.07N/A
    Dec 31, 2022-$2.02N/A
    Dec 31, 2021-$1.06N/A
    Dec 31, 2020-$0.33N/A
    Dec 31, 2019-$0.51N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q2 for the period ended Jun 30, 2026, runs about 5,600 words across 6 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q2Jun 30, 20265,6356
    2026Q1Mar 31, 20263,2626
    2025Q4Dec 31, 20256,0266
    2025Q3Sep 30, 20255,8187
    2025Q2Jun 30, 20255,5697
    2025Q1Mar 31, 20255,6087
    2024Q4Dec 31, 20246,6209
    2024Q3Sep 30, 20245,7937

    2026Q2 Earnings Call

    Opening remarks

    Mike Cavanaugh Investor Relations Good morning. Welcome to the Nano-X Imaging first quarter 2026 investor call. Earlier today, Nano-X Imaging Ltd. released financial results for the quarter ending March 31, 2026. The release is currently available on the investors section of the company's website. With me today are Erez Meltzer, Chief Executive Officer and Acting Chairman. Before we get started, I would like to remind everyone that management will be making statements during this call that include forward-looking statements regarding the company's financial results, research and development, manufacturing, commercialization activities, regulatory process, and clinical activities, and other matters. These statements are subject to risks, uncertainties and assumptions that are based on management's current expectations as of today and may not be updated in the future. These statements should not be relied upon as representing the company's views as of any subsequent date. Factors that may cause such a difference include, but are not limited to, those described in the company's filings with the Securities and Exchange Commission. We will also refer to certain non-GAAP financial measures to provide additional information to investors. A reconciliation of the non-GAAP to GAAP measures is provided with our press release, with the primary differences being non-GAAP net loss attributable to ordinary shares, non-GAAP cost of revenue, non-GAAP gross profit, non-GAAP gross profit margin, non-GAAP research and development expenses, non-GAAP sales and marketing expenses, non-GAAP general and administrative expenses, and non-GAAP gross loss per share. With that, I'd now like to turn the call over to Erez Meltzer.

    Erez Meltzer Chief Executive Officer and Acting Chairman Good morning. Thank you for joining us today for the Nano-X Imaging first quarter 2026 financial results conference call. I'm pleased to report that, as previously indicated, we are beginning to see early signs of revenue from Nanox.ARC. We are seeing momentum across multiple fronts, from record deployments to expanding partnerships supporting our technology and business model. We have worked diligently over the past two years to place a new technology in the medical imaging market. This process takes significant time and effort. We have learned many lessons during this time. We are using those lessons learned to help reshape our go-to-market strategy. Specifically, we have made various adaptations to our company strategy and operating model to better position us for long-term success. Changing behaviors is a long process. We need to educate customers not only on the medical utility of the Nanox systems, but also demonstrate why using them will benefit their practices financially. Here are some of the changes we have implemented based on lessons learned. First, we have restructured our U.S. commercial model to emphasize partnerships. This multi-channel approach supplements our direct sales efforts and provides broader market coverage more efficiently.

    Frequently Asked Questions About NNOX

    When is Nano X Imaging's next earnings date?

    Nano X Imaging's next earnings report is expected for Nov 25, 2026.

    Did NNOX beat earnings estimates last quarter?

    No. Nano X Imaging reported EPS of -$0.79 for the quarter ended Jun 30, 2026, below the -$0.12 estimate by 558.33%.

    What EPS do analysts expect from NNOX next quarter?

    The consensus EPS estimate for Nano X Imaging for the quarter ended Sep 30, 2026 is -$0.14 from 1 analyst, with estimates from -$0.14 to -$0.14.

    How often does NNOX beat earnings estimates?

    Nano X Imaging beat the EPS estimate in 1 of the last 8 quarters, with an average surprise of -78.68%.